...nternational, Inc.,(OTC Bulletin Board: BKYI), a l... wireless public safety, announced today that the ...issuance of a patent for the company,s "Match Temp..." method. , The benefits of the technology p...provide another layer of defense against hackers a...
...e today, it,s easy to forget that a dam and pond s...adison,s Franbrook Farm Research Station in southw...gone, and acres of plants, both native and weedy, ...theless, memories of the dam remain, and by diggin...ers are now unearthing them. Writing in a special ...
..., 2008. The first 5-year forest inventory report f...ailable to the public: California,s Forest Resourc...ysis Report., Here are some key findings from the ...te,s 100 million acres;19 million acres is publicl...terface account for most of the housing growth in ...
Other Biology News:BIO-key(R) Granted Patent to Secure Biometric Enrollments From Unauthorized Use 2Researchers examine role of soil patterns in dam restoration 2Researchers examine role of soil patterns in dam restoration 3Forest inventories in California include more than trees 2Forest inventories in California include more than trees 3(Date:11/18/2009)...., Nov. 18 Sangamo BioSc... data from the University of Pennsylvania investig...inc finger nuclease (ZFN) based product, SB-728-T,...isclosed on the internet. ,, Data were presente...vania School of Medicine from a single subject tre...
(Date:11/18/2009)...Nov. 18 Masimo (Nasdaq...nd Measure-Through Motion and Low-Perfusion pulse ...Uni.H.A., one of the largest healthcare Group Purc... multi-year purchasing agreement for "gold standar...ent offers preferred contract pricing to Uni.H.A.,...
(Date:11/18/2009)...ov. 18 Reportlinker.com announces ...its catalogue. ,, Biotechnology Reagents - A ...ortlinker.com/p0164375/Biotechnology-Reagents---A-...re&utm_medium=pr&utm_campaign=prnewswire ...chemical compounds used in a range of biotech rela...
(Date:11/18/2009)...romega Corporation and SwitchGear Genomics announc...teractions. , Madison, WI...tion and SwitchGear Genomics announce a novel meth...sults of a study using the HaloCHIP™ System ...e ability to correlate DNA binding events to trans...
Breaking Biology Technology:Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 3Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity 2... Quarter 2007: Total Net Revenue of $627 Million; ... EPS $0.35, Fiscal Year 2007: Total Net Revenue R... $1.27; 2007 Adjusted EPS $1.37, CORONA, Cal... WPI ), a leading specialty pharmaceutical,company... financial results,for its fiscal year ended Decem...
...IA, Md., Feb. 20 Cylex, Inc., today announced the...nical research study in,which the level of cellula...antation using the Company,s proprietary ImmuKnow(... patients that may be at risk for early,acute tran...he first three,months following transplantation., ...
..., Feb. 20 HealthAware, a leading supplier of,inno... today the launch of,VascularAware, the newest dis...rAware is designed to help people who may be at ri...cts nearly 10 million adult Americans,according to...the VascularAware disease module extends the Compa...
Other Biology Technology:Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 2Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 3Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 4Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 5Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 6Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 7Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 8Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 9Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 10Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 11Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 12Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 13Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 14Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 15Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 16Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 17Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 18New Independent Research Study Indicates That Cylex's ImmuKnow Test May Identify Kidney Transplant Patients at Risk for Early Acute Rejection 2New Independent Research Study Indicates That Cylex's ImmuKnow Test May Identify Kidney Transplant Patients at Risk for Early Acute Rejection 3HealthAware Introduces Its VascularAware Cardiovascular Disease Module 2GeneAmplimer HIV-1 Control Reagents from Applied Biosystems
GIBCO Versene 1:5;000 (1X); liquid from Invitrogen
Immunochemistry 1 & 2 from Promega
... • This book describes current strategies and...tibodies, the use of antibodies in immunoassays, t... latest ELISA techniques including amplification s...face molecules (cell-ELISA and ELISPOT procedures)...
Biology Products: